HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seyed Jalal Hosseinimehr Selected Research

EDDA (NiEDDA)

9/2021Effect of using different co-ligands during 99mTc-labeling of J18 peptide on SK-MES-1 cell binding and tumor targeting.
2/201899mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
1/2018An improved 99mTc-HYNIC-(Ser)3-LTVSPWY peptide with EDDA/tricine as co-ligands for targeting and imaging of HER2 overexpression tumor.
1/201899m Tc-HYNIC-(Ser)3 -J18 peptide: A radiotracer for non-small-cell lung cancer targeting.
8/2017Biological Evaluation of 99mTc-HYNIC-EDDA/tricine-(Ser)-D4 Peptide for Tumor Targeting.
1/2017Comparative assessment of a 99mTc labeled H1299.2-HYNIC peptide bearing two different co-ligands for tumor-targeted imaging.
2/2014An improved radiolabelled RNA aptamer molecule for HER2 imaging in cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seyed Jalal Hosseinimehr Research Topics

Disease

69Neoplasms (Cancer)
11/2022 - 12/2009
9Breast Neoplasms (Breast Cancer)
05/2022 - 01/2017
9Wounds and Injuries (Trauma)
01/2017 - 12/2008
8Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2012
7Burns
01/2017 - 12/2008
6Colonic Neoplasms (Colon Cancer)
01/2022 - 09/2012
6Pain (Aches)
02/2019 - 06/2010
5Inflammation (Inflammations)
11/2021 - 12/2014
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2017
4Glioblastoma (Glioblastoma Multiforme)
08/2022 - 02/2014
4Glioma (Gliomas)
08/2022 - 01/2020
3Carcinoma (Carcinomatosis)
09/2021 - 09/2012
3Head and Neck Neoplasms (Head and Neck Cancer)
07/2018 - 09/2015
3Necrosis
06/2018 - 01/2018
2Carcinogenesis
01/2020 - 04/2016
2Pruritus (Itching)
02/2019 - 01/2018
2Radiodermatitis
02/2019 - 01/2018
2Neoplasm Metastasis (Metastasis)
01/2019 - 12/2014
2Stomatitis
07/2018 - 03/2016
2Chromosome Aberrations (Chromosome Abnormalities)
10/2016 - 12/2009
2Genomic Instability
06/2015 - 11/2010
2Thyroid Neoplasms (Thyroid Cancer)
06/2014 - 01/2014
2Thyroid Diseases (Thyroid Disease)
04/2014 - 06/2013
1Lung Injury
11/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Atrophy
04/2021
1Colorectal Neoplasms (Colorectal Cancer)
03/2021
1Brain Neoplasms (Brain Tumor)
01/2021
1Fever (Fevers)
11/2020
1COVID-19
11/2020
1Cough
11/2020
1Infections
11/2020
1Cardiovascular Diseases (Cardiovascular Disease)
09/2020

Drug/Important Bio-Agent (IBA)

23Peptides (Polypeptides)IBA
11/2022 - 01/2017
8Radioisotopes (Radionuclides)IBA
11/2022 - 11/2012
8LigandsIBA
08/2022 - 02/2014
8tricineIBA
09/2021 - 02/2014
8Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2017 - 12/2008
7EDDA (NiEDDA)IBA
09/2021 - 02/2014
7Biological ProductsIBA
01/2021 - 01/2014
7RadiopharmaceuticalsIBA
12/2019 - 03/2011
5ErbB Receptors (EGF Receptor)IBA
01/2021 - 03/2011
4Paclitaxel (Taxol)FDA LinkGeneric
11/2022 - 01/2018
4Mefenamic Acid (Pontal)FDA Link
01/2022 - 09/2015
4Radiation-Sensitizing AgentsIBA
01/2022 - 01/2014
4Pharmaceutical PreparationsIBA
01/2019 - 11/2010
3Caspase 3 (Caspase-3)IBA
11/2022 - 06/2018
3leucyl- threonyl- valyl- seryl- prolyl- tryptophyl- tyrosineIBA
08/2022 - 02/2017
3Therapeutic UsesIBA
04/2021 - 01/2018
3human ERBB2 proteinIBA
01/2021 - 02/2017
3Monoclonal AntibodiesIBA
01/2021 - 01/2010
3Ointments (Pastes)IBA
05/2020 - 07/2015
3Atorvastatin (Lipitor)FDA Link
01/2020 - 01/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 01/2010
3DNA (Deoxyribonucleic Acid)IBA
01/2014 - 12/2009
2FebuxostatFDA Link
11/2022 - 11/2020
2Olanzapine (Zyprexa)FDA Link
01/2022 - 12/2019
2Testosterone (Sustanon)FDA Link
11/2021 - 06/2018
2Itraconazole (Sporanox)FDA LinkGeneric
04/2021 - 03/2021
2Single-Domain AntibodiesIBA
01/2021 - 01/2017
2C-Reactive ProteinIBA
11/2020 - 05/2020
2diphenyl (biphenyl)IBA
01/2019 - 10/2016
2CurcuminIBA
01/2019 - 06/2014
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2018 - 09/2012
2ceric oxide (cerium dioxide)IBA
01/2018 - 01/2018
2peptide AIBA
01/2018 - 01/2017
2Radiation-Protective Agents (Radiation Protectants)IBA
09/2015 - 12/2009
2Saline SolutionIBA
07/2015 - 06/2015
2Nucleotide AptamersIBA
02/2014 - 11/2013
2Bevacizumab (Avastin)FDA Link
09/2012 - 01/2010
2SilverIBA
01/2010 - 12/2008
1Xanthine OxidaseIBA
11/2022
1Immunoglobulin FragmentsIBA
08/2022
11,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2022
1Estradiol (Delestrogen)FDA LinkGeneric
05/2022
1Furosemide (Lasix)FDA LinkGeneric
01/2022
1hippuric acidIBA
01/2022
1AnionsIBA
01/2022
1CationsIBA
01/2022
1Cimetidine (Biomet)FDA LinkGeneric
01/2022
1Antipsychotic Agents (Antipsychotics)IBA
01/2022
1Estrogens (Estrogen)FDA Link
04/2021
1Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA
04/2021
1N-(3-pyridylmethyl)adriamycin (YM 1)IBA
04/2021
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2021
1Pimozide (Orap)FDA Link
01/2021
1Alkylating AgentsIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Neoplasm Antigens (Tumor Antigens)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1phenylpiperazineIBA
01/2021
1AntigensIBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2020

Therapy/Procedure

23Radiotherapy
01/2022 - 01/2014
19Therapeutics
11/2022 - 01/2010
8Drug Therapy (Chemotherapy)
11/2022 - 03/2016
2Contraindications
04/2021 - 11/2020
2Gamma Cameras (Gamma Camera)
01/2018 - 01/2018
1Injections
05/2022
1Aftercare (After-Treatment)
04/2021